Predictions
Verisign Inc.
Start price
Target price
Perf. (%)
€169.72
11.09.20
11.09.20
-
04.11.21
04.11.21
-1.60%
25.11.20
25.11.20
Probably not worthwhile Investment
Revenue decline/stagnation expected
Very low/no dividend yield expected
Bolloré S.A.
Start price
Target price
Perf. (%)
€3.24
11.09.20
11.09.20
€4.50
04.11.21
04.11.21
56.44%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Novozymes A/S B
Start price
Target price
Perf. (%)
€55.52
11.09.20
11.09.20
€63.00
04.11.21
04.11.21
18.70%
05.11.21
05.11.21
Market Leader or Top 3
Higher EBIT margin than peer group
positive Cash Flow expected
Revenue decline/stagnation expected
Samsung SDI Co. Ltd. GDR
Start price
Target price
Perf. (%)
€77.40
11.09.20
11.09.20
-
04.11.21
04.11.21
32.43%
22.11.20
22.11.20
Future proof or reliable business model
Market Leader or Top 3
Innovative
Well known brand
Satsuma Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€4.30
11.09.20
11.09.20
€2.00
04.11.21
04.11.21
16.74%
17.06.21
17.06.21
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Walter Bau-AG ST
Start price
Target price
Perf. (%)
€0.001
11.09.20
11.09.20
€0.002
24.09.20
24.09.20
300.00%
24.09.20
24.09.20
Undervalued
Risky Investment
High risks for its business
No Innovation
Kelly Services Inc. A
Start price
Target price
Perf. (%)
€14.30
10.09.20
10.09.20
-
15.09.20
15.09.20
-2.10%
15.09.20
15.09.20
Risky Investment
Geely Automobile Holdings
Start price
Target price
Perf. (%)
€1.72
10.09.20
10.09.20
-
04.11.21
04.11.21
32.36%
16.11.20
16.11.20
Some uniques
Below average Management
Business model of the past or high risk
Satsuma Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€5.60
10.09.20
10.09.20
-
19.09.20
19.09.20
-32.50%
19.09.20
19.09.20
Good culture
Could be very worthwhile Investment >20% year
Capable Management
Few uniques
News Corp. B
Start price
Target price
Perf. (%)
€12.60
10.09.20
10.09.20
-
04.11.21
04.11.21
18.25%
20.11.20
20.11.20
Low dividend yield expected
Revenue decline/stagnation expected
negative Cash Flow expected
Few uniques
Reconnaissance Energy Afri.ltd
Start price
Target price
Perf. (%)
€0.72
10.09.20
10.09.20
-
04.11.21
04.11.21
477.08%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Quantafuel ASA
Start price
Target price
Perf. (%)
€8.14
10.09.20
10.09.20
-
04.11.21
04.11.21
-69.26%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Lower EBIT Margin than peer group
High valuation
Amira Nature Food Ltd.
Start price
Target price
Perf. (%)
€1.58
10.09.20
10.09.20
-
04.11.21
04.11.21
463.29%
05.11.21
05.11.21
Fair valuation
Low dividend yield expected
negative Cash Flow expected
Bad rating
Curevac N.V.
Start price
Target price
Perf. (%)
€48.40
10.09.20
10.09.20
-
04.11.21
04.11.21
-26.12%
05.11.21
05.11.21
Revenue growth >5% per year expected
Higher EBIT margin than peer group
positive Cash Flow expected
Increased challenges to pay loans and raise capital
BioNTech SE ADR
Start price
Target price
Perf. (%)
€52.11
09.09.20
09.09.20
€85.00
19.10.20
19.10.20
58.30%
19.10.20
19.10.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Very Future proof/growth oriented business model
Capable Management
Urban One Inc.
Start price
Target price
Perf. (%)
€3.08
09.09.20
09.09.20
-
19.09.20
19.09.20
5.84%
19.09.20
19.09.20
EBIT decline > 20% expected
very negative Cash Flow expected
Junk rating
High challenges to pay loans and raise capital
Vaxart Inc.
Start price
Target price
Perf. (%)
€4.22
09.09.20
09.09.20
€8.00
04.11.21
04.11.21
42.75%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Eastman Kodak
Start price
Target price
Perf. (%)
€5.08
09.09.20
09.09.20
€13.00
19.09.20
19.09.20
94.49%
19.09.20
19.09.20
Could be worthwhile Investment >10% per year
Below average Marketposition
Very high cyclical dependencies
Little known brand
Panasonic Corp.
Start price
Target price
Perf. (%)
€7.65
09.09.20
09.09.20
-
04.11.21
04.11.21
14.30%
11.11.20
11.11.20
Some uniques
Future proof or reliable business model
Innovative
Differentiated customer and product portfolio
Commerce Resources Corp.
Start price
Target price
Perf. (%)
€0.026
09.09.20
09.09.20
€0.000
04.11.21
04.11.21
-
08.03.21
08.03.21
Moderna Inc.
Start price
Target price
Perf. (%)
€48.88
08.09.20
08.09.20
-
04.11.21
04.11.21
36.01%
11.11.20
11.11.20
Significant cyclical dependencies
Higher risks for its business
Corbus Pharmaceuticals Holding Inc.
Start price
Target price
Perf. (%)
€47.63
08.09.20
08.09.20
-
19.09.20
19.09.20
-4.25%
19.09.20
19.09.20
Could be worthwhile Investment >10% per year
Very bad culture
No uniques
Below average Management